This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jul;206(1):68.

doi: 10.1097/JU.0000000000001700.01. Epub 2021 Apr 12.

Editorial Comment

Christopher Morash¹

Affiliations

PMID: 33843257
DOI: 10.1097/JU.0000000000001700.01

Comment

Editorial Comment

Christopher Morash. J Urol. 2021 Jul.

. 2021 Jul;206(1):68.

doi: 10.1097/JU.0000000000001700.01. Epub 2021 Apr 12.

Author

Christopher Morash¹

Affiliation

¹ Division of Urology, University of Ottawa, Ottawa, Ontario, Canada.

PMID: 33843257
DOI: 10.1097/JU.0000000000001700.01

No abstract available

PubMed Disclaimer

Comment on

Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative.
Bruinsma SM, Nieboer D, Roobol MJ, Bangma CH, Verbeek JFM, Gnanapragasam V, Van Hemelrijck M, Frydenberg M, Lee LS, Valdagni R, Logothetis C, Steyerberg EW; the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Bruinsma SM, et al. J Urol. 2021 Jul;206(1):62-68. doi: 10.1097/JU.0000000000001700. Epub 2021 Feb 22. J Urol. 2021. PMID: 33617330

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations